Cannabis Science Releases Cannabinoid-Formulated Capsule Product Line in California

Warning message

The subscription service is currently unavailable. Please try again later.

COLORADO SPRINGS, CO - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based formulation, announces the launch of their cannabinoid-formulated capsule product line. The initial capsule formulations released are CBD, Indica, and Sativa; each of the three types of caps will be available in 25mg, 50mg, and 100mg doses and will be provided in two-dose packs with more size options to be made available in the near future.

"We are very excited to get our next line of Cannabis Science Brand Products on the market. The Capsules are important because of the popularity and ease of the delivery mechanism. The Company reps have already begun distributing to a number of dispensaries throughout California. They anticipate the Caps to be in a much larger number of dispensaries, and look forward to being able to line the shelves with a full lineup of Cannabis Science Brand Health-Related...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.